DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Induction therapy
Short course immune induction therapy
Short Course Immune Induction Therapy or SCIIT, is a therapeutic strategy employing rapid, specific, short term-modulation of the immune system using a therapeutic agent to induce T-cell non-responsiveness, also known as operational tolerance. As an alternative strategy to immunosuppression and antigen-specific tolerance inducing therapies, the primary goal of SCIIT is to re-establish or induce peripheral immune tolerance in the context of autoimmune disease and transplant rejection through the use of biological agents. In recent years, SCIIT has received increasing attention in clinical and research settings as an alternative to immunosuppressive drugs currently used in the clinic, drugs which put the patients at risk of developing infection, cancer, and cardiovascular disease.
Induction therapy - List of case studies
- Multirelapse Squamed Carcinoma of the Skin
-
dose, followed by 250 mg/mq maintenance) - Symptomatic therapy: Omeprazen 20 mg 1 tablet; Medrol 16 mg 1/2 tablet x 2 (on a ... (EGFR) may have an impact. We evaluated gefitinib as an induction therapy in a high-risk patient (pt) group prior to definitive therapy ...
- Neurofibromatosis type 1 - Ophthalmologic Exam is recommended
-
Do you agree with the need for starting a therapy at the present stage of disease? as advised by the Policlinico San ... function. ( 2) Would the SIOP induction carboplatin/vincristine chemotherapy be the correct plan if treatment ...
- IgG Multiple Myeloma
-
followed by thalidomide. The disease has responded to therapy. questions: ... Peripheral Blood Stem Cell transplantation , after induction with 200mg/mm Melfalan (overall 400mg in two days). Post ...
- Multiple Myeloma (MM) and Cardiomyopathy
-
or combined. The patient received anti-MM induction type of treatment (VTD combination), followed by high-dose ... or combined. The patient received anti-MM induction type of treatment, including bortezomib (velcade), thalidomide and ... of MM in a young patient is to induce with an anti-MM therapy , and this can be achieved by a combination of 2-3 medications , ...
- Drugs
-
Anti-oxidant supplements Anti-platelet therapy Antiangiogenic antibody Avastin Antiarrhythmic treatment Antibiotic Antibiotic therapy Antibiotics Antibody therapy Anticholinergic agents ... Inderal Indobufen Indoxen Induction chemotherapy Infusional 5-fluoropyrimidine (ECF) Infusional ...
- Stage 4 Neuroblastoma
-
protocol , that schedules a first phase of induction chemotherapy according to the COJEC scheme (8 cycles of ... Vincristine and Etoposide has been administered. The therapy has been, on the whole, well tolerated.” June, 2009 : ... Pinkerton, CR, et al. "High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 ...
- Treatments
-
Abundant hydration Acupuncture Acupuncture therapy Acupuncture treatment Adaptation training exercises ... Anti-HZV antibody Anti-MM therapy Anti-MM induction type of treatment Anti-MM therapy Anti-aggregating agents ...
- Autoimmune hepatitis/cholangitis in patient with Crohn’s disease.
-
as a light pancreatitis (treated with antibiotic therapy). Subsequently, persisting painful crises were observed despite blood ... to assess his disease score before and after remicade induction. If results are favorable, he can be put in a Remicade maintenance ...
- Pulmonary heteroplasia
-
patient was then treated with altogether four courses of induction chemotherapy. questions: ... Apparently, following one of his suggestions, a therapy with daily 150mg of the EGFR-targeted tyrosin kinase inhibitor ...
- Stage 4 Neuroblastoma – additional opinion
-
protocol , that schedules a first phase of induction chemotherapy according to the COJEC scheme (8 cycles of ... Vincristine and Etoposide has been administered. The therapy has been, on the whole, well tolerated.” June, 2009 : ... protocol and until now received several cycles of the induction therapy. The diagnosis is completely obvious in view of the ...